Research Solutions (RSx)

Our platform is designed specifically for tracking outcomes on minimally invasive orthopedic treatments. This includes regenerative medicine, biologics and various new and emerging treatments for musculoskeletal conditions. We offer customization to add tracking for new therapies on a case-by-case basis.

We like to think of our database as a "next-generation registry" — making real-world data insightful and actionable. Our ReGENius Insights Engine powers the most comprehensive orthobiologic registry that Performance members and Insights subscribers can leverage. Our core infrastructure also allows us to support the development of various other custom registries, studies, and data cohorts.

We're creating more than just a data collection platform. Our deep ties to top providers in the field and our industry agnostic platform has allowed us to develop a coalition of data-driven clinicians. Our mission is to support all who believe in advancing data-backed medicine. Being a contributor to DataBiologics does not signify any endorsement. As we grow our network, we intend to work with our members to develop a pathway to validate top performers.

We believe in data transparency which is why we use a data co-ownership agreement which allows clinics to own their collected data as well as allowing DataBiologics a license to the de-identified data for research or commercial purposes. Data is retained by both the client and DataBiologics as defined by the terms of the Services Agreement. No PHI is ever sold, shared or distributed.

DataBiologics keeps data protected by using strong encryption, strict access controls, and regular security checks. Patient data is stored securely within HIPAA-compliant data servers, and personal information is de-identified to protect privacy.